A study published in this issue of Heart explores the associations between plasma osteoprotegerin (OPG) collected within 48 h of the onset of symptoms of a non-ST elevation acute coronary syndrome (NSTE-ACS) and 30 day and 1 year incidence of cardiovascular death.1 A strong association was observed between OPG and cardiovascular mortality, and baseline OPG was also an independent predictor of new or worsening heart failure (HF).
Campia, U., Tesauro, M., Cardillo, C., Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque, <<Heart (British Cardiac Society)>>, 2012; 98 (10): 762-763. [doi:10.1136/heartjnl-2012-301710] [http://hdl.handle.net/10807/56639]
Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque
Cardillo, Carmine
2012
Abstract
A study published in this issue of Heart explores the associations between plasma osteoprotegerin (OPG) collected within 48 h of the onset of symptoms of a non-ST elevation acute coronary syndrome (NSTE-ACS) and 30 day and 1 year incidence of cardiovascular death.1 A strong association was observed between OPG and cardiovascular mortality, and baseline OPG was also an independent predictor of new or worsening heart failure (HF).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.